Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study

Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients

“…Based on multivariate linear regression modeling, factors associated significantly and independently with serum lipid concentrations and their decreases during six-months of follow-up included higher BMI, older current age, and diagnosis of BD (Table 3), whereas higher serum lipid and glucose concentrations with older age would be expected [17,28,29]. As already noted, the association of obesity with BD may reflect risks associated with the disorder itself, with its often complex and sometimes unsatisfactory treatment, or, very likely, both [5,7,11,24].…”

Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention

“…Despite increased awareness and general acceptance of these guidelines, appropriate metabolic monitoring has remained uncommon. In fact, several studies concluded that the publication of these guidelines in 2004 did not increase metabolic testing in patients initiating SGA therapy . One reason for this may be the uncertainty regarding the role of psychiatrists in directly managing metabolic abnormalities themselves.…”

“…In fact, several studies concluded that the publication of these guidelines in 2004 did not increase metabolic testing in patients initiating SGA therapy. [3][4][5] One reason for this may be the uncertainty regarding the role of psychiatrists in directly managing metabolic abnormalities themselves. One study by Newcomer et al 6 found that approximately half of the psychiatrists surveyed agreed that general healthcare management was outside of their scope of practice, with nearly three-quarters of these respondents stating they would seek consultation for management of adverse metabolic effects.…”